Prevalence and definition of drooling in Parkinson's disease: a systematic review
- PMID: 19288042
- PMCID: PMC2733191
- DOI: 10.1007/s00415-009-5098-2
Prevalence and definition of drooling in Parkinson's disease: a systematic review
Abstract
Drooling (saliva loss) is a frequently reported symptom in patients with Parkinson's disease (PD), but an accurate estimate of the prevalence of drooling is lacking. The aim of this study was to systematically review the prevalence of drooling in published research papers. A systematic PubMed and CINAHL search was done, including studies published until January 2009. Eight studies were found, presenting prevalence rates of drooling based on responses of PD patients to questionnaires. The statistical heterogeneity was highly significant (P < 0.0001), with prevalence rates ranging from 32 to 74%. The pooled prevalence estimate with random effect analysis was of 56% (95% CI 44-67) for PD patients and 14% (95% CI 3-25) for healthy controls; the pooled relative risk (RR) with random effect analysis was 5.5 (95% CI 2.1-14.4). All studies reported data of community dwelling idiopathic PD patients, with a mean age around 65 years and mild PD in 50-60% of the cases. Heterogeneity was mainly caused by differences in definition or frequency of drooling. The highest prevalence rates included nocturnal drooling where others noted only diurnal drooling. Analysis of the data of two studies showed that drooling is reported frequently by 22-26% of the patients. Prevalence rates were lower in milder PD patients. The summarized findings demonstrate that drooling can be present in half of all PD patients. In about a quarter of PD patients, drooling appears to be a frequently occurring problem. We recommend to report drooling in future studies with more detailed consideration of severity, frequency and nocturnal versus diurnal complaints.
Figures
Similar articles
-
Impact of drooling in Parkinson's disease.J Neurol. 2007 Sep;254(9):1227-32. doi: 10.1007/s00415-007-0508-9. Epub 2007 Aug 2. J Neurol. 2007. PMID: 17671806
-
Diurnal and nocturnal drooling in Parkinson's disease.J Neurol. 2012 Jan;259(1):119-23. doi: 10.1007/s00415-011-6138-2. Epub 2011 Jun 23. J Neurol. 2012. PMID: 21698387 Free PMC article.
-
Drooling in Parkinson's Disease: Evidence of a Role for Divided Attention.Dysphagia. 2018 Dec;33(6):809-817. doi: 10.1007/s00455-018-9906-7. Epub 2018 May 21. Dysphagia. 2018. PMID: 29785679
-
Clinical features associated with drooling in Parkinson's disease.Neurol Sci. 2021 Mar;42(3):895-903. doi: 10.1007/s10072-020-05005-0. Epub 2021 Jan 14. Neurol Sci. 2021. PMID: 33443673 Review.
-
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.Mov Disord. 2009 Apr 15;24(5):635-46. doi: 10.1002/mds.22260. Mov Disord. 2009. PMID: 19205066 Free PMC article. Review.
Cited by
-
Olfactory dysfunction in patients with Parkinson's disease: A systematic review and meta-analysis.Curr J Neurol. 2023 Oct 7;22(4):249-254. doi: 10.18502/cjn.v22i4.14530. Curr J Neurol. 2023. PMID: 38425360 Free PMC article. Review.
-
The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis.BMC Pharmacol Toxicol. 2023 Oct 12;24(1):52. doi: 10.1186/s40360-023-00694-7. BMC Pharmacol Toxicol. 2023. PMID: 37828600 Free PMC article.
-
Dysphagia in Parkinson Disease: Part I - Pathophysiology and Diagnostic Practices.Curr Phys Med Rehabil Rep. 2023 Jun;11(2):176-187. doi: 10.1007/s40141-023-00392-9. Epub 2023 Mar 28. Curr Phys Med Rehabil Rep. 2023. PMID: 37608845 Free PMC article.
-
Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group.Parkinsons Dis. 2023 Apr 6;2023:3104425. doi: 10.1155/2023/3104425. eCollection 2023. Parkinsons Dis. 2023. PMID: 37065970 Free PMC article.
-
Reliability and Validity Study of a Turkish Version of the Sialorrhea Clinical Scale for Parkinson's Disease (SCS-TR).Noro Psikiyatr Ars. 2022 Dec 5;60(1):49-54. doi: 10.29399/npa.28053. eCollection 2023. Noro Psikiyatr Ars. 2022. PMID: 36911563 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.parkreldis.2007.09.002', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.parkreldis.2007.09.002'}, {'type': 'PubMed', 'value': '18042421', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/18042421/'}]}
- Cheon SM, Ha MS, Park MJ, Kim JW (2008) Nonmotor symptoms of Parkinson’s disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord 14:286–290. doi:10.1016/j.parkreldis.2007.09.002 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15477545', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/15477545/'}]}
- de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of Parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63:1240–1244 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '14271784', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/14271784/'}]}
- Eadie MJ, Tyrer JH (1965) Alimentary disorder in Parkinsonism. Australas Ann Med 14:13–22 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/mds.870060211', 'is_inner': False, 'url': 'https://doi.org/10.1002/mds.870060211'}, {'type': 'PubMed', 'value': '2057006', 'is_inner': True, 'url': 'http://pubmed.ncbi.nlm.nih.gov/2057006/'}]}
- Edwards LL, Pfeiffer RF, Quigley EM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156. doi:10.1002/mds.870060211 - PubMed
-
- None
- Egger M, Smith GD, Altman DG (2001) Sytematic reviews in health care: meta-analysis in context. Blackwell BMJ Books, London
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical